The effect of delays in treatment for breast cancer metastasis on survival

[1]  D. Reidpath,et al.  Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran , 2009, BMC Cancer.

[2]  T. Ahern,et al.  Impact of Acquired Comorbidities on All-Cause Mortality Rates Among Older Breast Cancer Survivors , 2009, Medical care.

[3]  M. Bottai,et al.  Breast Cancer Survival among Economically Disadvantaged Women: The Influences of Delayed Diagnosis and Treatment on Mortality , 2008, Cancer Epidemiology Biomarkers & Prevention.

[4]  A. Rosman,et al.  Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome. , 2008, The American journal of cardiology.

[5]  Samy Suissa,et al.  Immortal time bias in pharmaco-epidemiology. , 2008, American journal of epidemiology.

[6]  J. Heck,et al.  Killing time: Treatment delay and breast cancer survival , 2007 .

[7]  Samy Suissa,et al.  Immortal time bias in observational studies of drug effects , 2007, Pharmacoepidemiology and drug safety.

[8]  A. Luini,et al.  Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature , 2007, Breast Cancer Research and Treatment.

[9]  S. S. Sheinfeld Gorin,et al.  Effect of race/ethnicity and treatment delay on breast cancer survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  W. Ray.  Observational studies of drugs and mortality. , 2005, The New England journal of medicine.

[11]  A. Neugut,et al.  Racial disparities in treatment and survival among women with early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Wingo,et al.  Body Mass and Mortality After Breast Cancer Diagnosis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  J. Elmore,et al.  Racial Inequities in the Timing of Breast Cancer Detection, Diagnosis, and Initiation of Treatment , 2005, Medical care.

[14]  R. Rouzier,et al.  Breast cancer with synchronous metastases: trends in survival during a 14-year period. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Jenny C. Chang,et al.  Survival of patients with metastatic breast carcinoma , 2003, Cancer.

[16]  J. Kievit.  [The effect of treatment delay on the prognosis of breast cancer patients]. , 2002, Nederlands tijdschrift voor geneeskunde.

[17]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[18]  K. McGinn,et al.  Metastatic breast cancer: understanding current management options. , 2001, Oncology nursing forum.

[19]  Ana Lluch,et al.  Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients , 1999, Breast Cancer Research and Treatment.

[20]  P. Littlejohns,et al.  Influence of delay on survival in patients with breast cancer: a systematic review , 1999, The Lancet.

[21]  Philip Smith,et al.  The influence on survival of delay in the presentation and treatment of symptomatic breast cancer , 1999, British Journal of Cancer.

[22]  G. Hortobagyi,et al.  Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[24]  R. Gelman,et al.  Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  T. Powles,et al.  An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer. , 1986, European journal of cancer & clinical oncology.

[26]  A. Antunez,et al.  Results of conservative operations for breast cancer. , 1985, Archives of surgery.

[27]  M. Charlson.  Delay in the treatment of carcinoma of the breast. , 1985, Surgery, gynecology & obstetrics.

[28]  B. Tilley,et al.  Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer , 1985, Cancer.

[29]  K. Cummings,et al.  Delay, stage of disease, and survival among White and Black women with breast cancer. , 1983, American journal of public health.

[30]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[31]  B. Lim,et al.  Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer , 1975, Cancer.

[32]  R. Lawson.  THE EFFECTS OF DELAY IN TREATMENT ON SURVIVAL RATES IN CARCINOMA OF THE BREAST , 1971, The Medical journal of Australia.

[33]  M. Laberge.  [Cancer of the breast]. , 1961, Laval medical.

[34]  C. Eggers,et al.  CANCER OF THE BREAST , 1941, Annals of surgery.

[35]  M. Roizen.  Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients , 2010 .

[36]  D. Berthold.  Third consensus on medical treatment of metastatic breast cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  B. Zakotnik,et al.  Risk factors for late relapse and death in patients with early breast cancer. , 2008, Neoplasma.

[38]  D. May,et al.  Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. , 2000, American journal of public health.

[39]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[40]  H. Sommer,et al.  Patient's and doctor's delay in primary breast cancer. Prognostic implications. , 1994, Acta oncologica.

[41]  C. Vallejo,et al.  Relation between delay and survival in 596 patients with breast cancer. , 1989, Oncology.

[42]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[43]  B. Tilley,et al.  Marital status, delay in seeking treatment and survival from breast cancer. , 1986, Social science & medicine.

[44]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[45]  J. Pater,et al.  A multivariate analysis of the contribution of "auxometry" to prognosis in breast cancer. , 1979, Journal of chronic diseases.

[46]  B. Gardner.  The relationship of delay in treatment to prognosis in human cancer. , 1978, Progress in clinical cancer.